Endostatin gene therapy for liver cancer by a recombinant adenovirus delivery

doi:10.3748/wjg.v10.i13.1867

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 10, Issue 13

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (2882)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-6) series.

Item

Count

PDF

300

HTML

2388

Figures (1-6)

194

Sum=2882

Jul 1, 2004 (publication date) through Jul 17, 2024

Times Cited of This Article

Times Cited (25)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Liver Cancer

World J Gastroenterol. Jul 1, 2004; 10(13): 1867-1871
Published online Jul 1, 2004. doi: 10.3748/wjg.v10.i13.1867

Full Size Figure Download Figure

Figure 1 Immunohistochemistry analysis for endostatin pro-tein in vitro (× 100). Extensive positive staining was observed in the cytoplasm of transduced cells. This indicated that human endostatin gene mediated by recombinant adenovirus was highly expressed in BEL-7402 cells.

Citation: Li L, Huang JL, Liu QC, Wu PH, Liu RY, Zeng YX, Huang WL. Endostatin gene therapy for liver cancer by a recombinant adenovirus delivery. World J Gastroenterol 2004; 10(13): 1867-1871
URL: https://www.wjgnet.com/1007-9327/full/v10/i13/1867.htm
DOI: https://dx.doi.org/10.3748/wjg.v10.i13.1867